The most important financial indicators for the company Advanced Clinical Research Srl - Unique Identification Number 36208364:
sales in 2023 was
36.648
euro, registering a net profit of
19.589
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in biotehnologie having the NACE code 7211.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -0.3%, from 36.884 euro in the year 2022, to 36.648 euro in 2023.
The Net Profit decreased by -5.905 euro, from 25.572 euro in 2022, to 19.589 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Advanced Clinical Research Srl - CUI 36208364
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
128
126
0
0
25.854
19.557
13.876
8.109
Current Assets
-
-
327
14.809
29.273
35.129
39.360
51.016
29.441
43.113
Inventories
-
-
0
0
0
0
0
0
0
0
Receivables
-
-
0
0
2.738
14.439
10.585
2.330
2.572
3.489
Cash
-
-
327
14.809
26.536
20.690
28.776
48.686
26.870
39.624
Shareholders Funds
-
-
224
14.365
27.450
34.487
50.980
59.323
25.621
45.133
Social Capital
-
-
45
44
43
42
41
40
41
40
Debts
-
-
231
570
1.823
643
14.382
11.579
17.717
6.108
Income in Advance
-
-
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7211 - 7211"
CAEN Financial Year
7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
43.113 euro in 2023 which includes Inventories of
0 euro, Receivables of
3.489 euro and cash availability of
39.624 euro.
The company's Equity was valued at
45.133 euro, while total Liabilities amounted to
6.108 euro.
Equity increased by 19.589 euro, from 25.621 euro in 2022, to 45.133 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Advanced Clinical Research Srl